Revisão sistemática | Ocrelizumabe para esclerose múltipla.
26 Mai, 2022 | 12:47hOcrelizumab for multiple sclerosis – Cochrane Library
Resumo: What are the benefits and risks of ocrelizumab for multiple sclerosis? – Cochrane Library
Acesso livre